Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611) ...

INGELVAC CIRCOFLEX ® AD is the first vaccine to provide protection against the most prevalent genotypes of porcine circovirus type 2 (PCV2), combining PCV2a and PCV2d antigens in a single dose. PCV2 ...

From the publication pyPept: a python library to generate atomistic 2D and 3D representations of peptides Journal of Cheminformatics, 2023, 15:79 Authors: Rodrigo Ochoa, J.B Brown, Thomas Fox Here we ...

KUALA LUMPUR, Aug 25 (Bernama) -- Boehringer Ingelheim Malaysia is ramping up its prevention mission on the epidemic through the 2025 phase of its Stop Rabies Campaign, which is now targeting rural ...

The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and losers. Here are five molecules that never made it to the market.

In short, family-owned German multinational pharma giant Boehringer Ingelheim’s purpose is to improve the health and quality of life of patients through constant innovation, and the strategic use of ...

With top-line phase 3 results in sight, Rezolute has stepped up preparations for a planned rare disease launch by appointing Sunil Karnawat as its chief commercial officer. Rezolute recently completed ...

Nucleus RadioPharma, a CDMO that specializes in the burgeoning field of radiopharmaceuticals, named former FDA Commissioner Dr. Stephen Hahn as its chief executive officer. Hahn, who led the federal ...

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, announced the signing of a contract development and manufacturing agreement with AnGes Inc. for the drug ...

Boehringer Ingelheim partners with AnGes to develop HGF gene therapy for peripheral arterial disease, following AnGes' clinical trial completion. AnGes plans to submit a Biologics License Application ...

The framework agreement imposes tariffs on EU imports, including pharmaceuticals, capped at 15%, with an MFN clause potentially reducing tariffs. President Trump has emphasized domestic pharmaceutical ...